The WACC of Bioera SpA (BIE.MI) is 7.6%.
Range | Selected | |
Cost of equity | 12.7% - 18.6% | 15.65% |
Tax rate | 0.3% - 1.6% | 0.95% |
Cost of debt | 7.0% - 7.0% | 7% |
WACC | 7.4% - 7.7% | 7.6% |
Category | Low | High |
Long-term bond rate | 3.7% | 4.2% |
Equity market risk premium | 8.3% | 9.3% |
Adjusted beta | 1.08 | 1.5 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 12.7% | 18.6% |
Tax rate | 0.3% | 1.6% |
Debt/Equity ratio | 12.98 | 12.98 |
Cost of debt | 7.0% | 7.0% |
After-tax WACC | 7.4% | 7.7% |
Selected WACC | 7.6% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
BIE.MI | Bioera SpA | 12.98 | -0.02 | 0 |
ENV.MI | Enervit SpA | 0.16 | 0.15 | 0.13 |
HRP.WA | Harper Hygienics SA | 3.7 | 0.3 | 0.06 |
MPH.WA | Master Pharm SA | 0.05 | 0.35 | 0.34 |
MSON B.ST | Midsona AB | 0.47 | 0.06 | 0.04 |
NATTO.OL | Nattopharma ASA | 0.02 | 1.22 | 1.19 |
NICO.ST | Nicoccino Holding AB (publ) | 0.04 | -1.08 | -1.04 |
NNH.ST | New Nordic Healthbrands AB | 0.3 | 0.12 | 0.09 |
PAP.AT | Papoutsanis Industrial and Commercial of Consumer Goods SA | 0.36 | 0.51 | 0.37 |
SIS.L | Science in Sport PLC | 0.16 | 0.14 | 0.12 |
Low | High | |
Unlevered beta | 0.08 | 0.13 |
Relevered beta | 1.12 | 1.75 |
Adjusted relevered beta | 1.08 | 1.5 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BIE.MI:
cost_of_equity (15.65%) = risk_free_rate (3.95%) + equity_risk_premium (8.80%) * adjusted_beta (1.08) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.